← Leaderboards
Jeffrey R Fineman
University Of California San Francisco
$18,796,963
Attributed
$24,470,046
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,470,046 · 11
By mechanism
R01$10,997,614 · 2
P01$4,874,202 · 4
T32$4,371,995 · 2
R44$4,198,675 · 1
M01$27,560 · 2
Top collaborators
- Emin Maltepe6 shared
- Jonathan A Winger5 shared
- Steven Herbert Abman4 shared
- Eric Douglas Austin4 shared
- Stephen M Black4 shared
- Heidi M. Mansour4 shared
- Ana Krtolica2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Sunil P Malhotra$49,265
- Michael A. Matthay$26,142,041
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodNitric OxideHemodynamicsBlood FlowChildLungShunt DeviceCongenital Heart DefectsClinically RelevantBlood VesselsOperative Surgical ProceduresInfantMorbidity - Disease RateResearch TrainingCongenital Heart DisorderCardiopulmonaryShear StressDesignIn VivoAttenuatedProductionAnimal ModelCritical CareMedicine
Grant awards (64)
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$991,379
R44 · FY2025 · HD
Animal Model & Clinical Core$587,098
P01 · FY2025 · HL · contact PI
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$366,737
T32 · FY2025 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$201,346
T32 · FY2025 · HD · contact PI
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$995,592
R44 · FY2024 · HD
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$387,294
T32 · FY2024 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$181,434
T32 · FY2024 · HD · contact PI
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$999,580
R44 · FY2023 · HD
Animal and Clinical Core$661,849
P01 · FY2023 · HL · contact PI
Endothelial mechanotransduction and metabolic remodeling$403,174
P01 · FY2023 · HL · contact PI
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$376,328
T32 · FY2023 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$142,856
T32 · FY2023 · HD · contact PI
Animal and Clinical Core$661,849
P01 · FY2022 · HL · contact PI
Endothelial mechanotransduction and metabolic remodeling$399,352
P01 · FY2022 · HL · contact PI
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease$358,400
T32 · FY2022 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$184,744
T32 · FY2022 · HD · contact PI
Animal and Clinical Core$661,786
P01 · FY2021 · HL · contact PI
Endothelial mechanotransduction and metabolic remodeling$399,352
P01 · FY2021 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$159,095
T32 · FY2021 · HD · contact PI
Animal and Clinical Core$687,545
P01 · FY2020 · HL · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2020 · HL
Endothelial mechanotransduction and metabolic remodeling$412,197
P01 · FY2020 · HL · contact PI
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$232,127
R44 · FY2020 · HD
Research Training in Pediatric Critical Care Medicine$160,163
T32 · FY2020 · HD · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2019 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$681,601
R44 · FY2019 · HD
Research Training in Pediatric Critical Care Medicine$151,166
T32 · FY2019 · HD · contact PI
Perinatal NO signaling in congenital heart disease$682,425
R01 · FY2018 · HL
Research Training in Pediatric Critical Care Medicine$170,586
T32 · FY2018 · HD · contact PI
Perinatal NO signaling in congenital heart disease$689,715
R01 · FY2017 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass$298,396
R44 · FY2017 · HD
Research Training in Pediatric Critical Care Medicine$158,452
T32 · FY2017 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$676,672
R01 · FY2016 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$151,020
T32 · FY2016 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$662,414
R01 · FY2015 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$142,761
T32 · FY2015 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$654,922
R01 · FY2014 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$144,130
T32 · FY2014 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$665,026
R01 · FY2013 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$141,259
T32 · FY2013 · HD · contact PI
Research Training in Pediatric Critical Care Medicine$135,148
T32 · FY2012 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$569,182
R01 · FY2011 · HL · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$575,333
R01 · FY2010 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$129,517
T32 · FY2010 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$572,543
R01 · FY2009 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$131,635
T32 · FY2009 · HD · contact PI
Perinatal Pulmonary Hypertension: Developmental Mediators$573,198
R01 · FY2008 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$119,050
T32 · FY2008 · HD · contact PI
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORS$464,087
R01 · FY2007 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$136,206
T32 · FY2007 · HD · contact PI
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORS$461,537
R01 · FY2006 · HL · contact PI
Research Training in Pediatric Critical Care Medicine$142,668
T32 · FY2006 · HD · contact PI
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORS$459,288
R01 · FY2005 · HL
ADMA LEVELS BEFORE AND AFTER CARDIOPULMONARY BYPASS IN CHILDREN WITH CHD$1,761
M01 · FY2005 · RR
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORS$444,978
R01 · FY2004 · HL
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORS$463,405
R01 · FY2003 · HL
PERINATAL PULMONARY HYPERTENSION--DEVELOPMENTAL MEDIATOR$349,781
R01 · FY2002 · HL
INHALED NO IN TREATMENT OF PPHN--DOSE RESPONSE$0
M01 · FY2002 · RR
PERINATAL PULMONARY HYPERTENSION--DEVELOPMENTAL MEDIATOR$339,657
R01 · FY2001 · HL
INHALED NO IN TREATMENT OF PPHN--DOSE RESPONSE$0
M01 · FY2001 · RR
PERINATAL PULMONARY HYPERTENSION--DEVELOPMENTAL MEDIATOR$328,601
R01 · FY2000 · HL
INHALED NO IN TREATMENT OF PPHN--DOSE RESPONSE$25,799
M01 · FY2000 · RR
INHALED NO IN TREATMENT OF PPHN--DOSE RESPONSE$0
M01 · FY2000 · RR
INHALED NO IN TREATMENT OF PPHN--DOSE RESPONSE$0
M01 · FY2000 · RR